The cardiac glycoside digoxin does not alter the activity of human polymorphonuclear leukocytes in vitro.
Esposito
A L
AL
Department of Medicine, Boston Veterans Administration Medical Center 02130.
Clark
C A
CA
Poirier
W J
WJ
D000328:Adult; D001770:Blood Bactericidal Activity / Q000187:drug effects; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D004077:Digoxin / Q000097:blood / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology*; D009895:Opsonin Proteins; D013481:Superoxides / Q000097:blood; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D015054:Zymosan / Q000494:pharmacology
D009895:Opsonin Proteins; D013481:Superoxides; D009240:N-Formylmethionine Leucyl-Phenylalanine; D004077:Digoxin; D015054:Zymosan; D013755:Tetradecanoylphorbol Acetate